Literature DB >> 28839714

Gallbladder perforation following transarterial chemoembolisation; a rare but serious complication.

Eu Jin Lim1,1, Manfred Spanger2,1, John S Lubel1,2.   

Abstract

Transarterial chemoembolisation (TACE) is the mainstay of treatment for large or multifocal hepatocellular carcinoma (HCC). However, this procedure is not without potential complications. We report the case of a 72-year-old man with cirrhosis with HCC treated by TACE using drug-eluting beads. He developed persistent fever and severe right upper quadrant pain post-procedure. CT abdomen revealed a large fluid collection closely abutting the gallbladder and tracking inferiorly along the right flank. This fluid collection originated from the gallbladder and contained locules of gas with a contrast-enhancing wall, consistent with an infected biloma. These imaging findings confirmed gallbladder perforation complicating TACE. The development of gallbladder perforation post-TACE from acute ischaemic cholecystitis producing gallbladder wall necrosis is exceedingly rare. The presence of gallbladder perforation must be recognised in patients with persisting symptoms and imaging evidence of a perihepatic fluid collection because specific treatment with intravenous antibiotics and percutaneous drainage of the biloma is necessary.

Entities:  

Year:  2013        PMID: 28839714      PMCID: PMC5369796          DOI: 10.1136/flgastro-2012-100216

Source DB:  PubMed          Journal:  Frontline Gastroenterol        ISSN: 2041-4137


  3 in total

Review 1.  Transarterial (chemo)embolisation for unresectable hepatocellular carcinoma.

Authors:  Roberto S Oliveri; Jørn Wetterslev; Christian Gluud
Journal:  Cochrane Database Syst Rev       Date:  2011-03-16

2.  Acute ischemic cholecystitis after transarterial chemoembolization of hepatocellular carcinoma: incidence and clinical outcome.

Authors:  Ute Wagnetz; Jeff Jaskolka; Peter Yang; Kartik S Jhaveri
Journal:  J Comput Assist Tomogr       Date:  2010 May-Jun       Impact factor: 1.826

Review 3.  Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival.

Authors:  Josep M Llovet; Jordi Bruix
Journal:  Hepatology       Date:  2003-02       Impact factor: 17.425

  3 in total
  1 in total

1.  Transarterial chemoembolization with pirarubicin-eluting microspheres in patients with unresectable hepatocellular carcinoma: Preliminary results.

Authors:  Mingjun Bai; Tao Pan; Churen Zhou; Ming-An Li; Junwei Chen; Zhaolin Zeng; Duo Zhu; Chun Wu; Zaibo Jiang; Zhengran Li; Mingsheng Huang
Journal:  J Interv Med       Date:  2019-09-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.